{'text': 'Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel', 'publisher': {'href': 'https://www.nature.com', 'title': 'Nature.com'}, 'created_at': 'Tue, 02 Jun 2015 07:00:00 GMT', 'description': 'Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel  Nature.com', 'url': 'https://news.google.com/rss/articles/CBMiVEFVX3lxTE12b0JpcnFPSHp0ZFZJWkNkMEFBYTJNVVU3cExPTkx1Y21qOWphUjR4b0JuOUhfdjVac1RmcGNGbUQ3UThoWTY2eW5tNU9wNEhjeXRuRg?oc=5&hl=en-US&gl=US&ceid=US:en'}
